Proficio Capital Partners LLC Makes New $5.78 Million Investment in ICU Medical, Inc. (NASDAQ:ICUI)

Proficio Capital Partners LLC purchased a new stake in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 37,241 shares of the medical instruments supplier's stock, valued at approximately $5,779,000. Proficio Capital Partners LLC owned about 0.15% of ICU Medical as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in ICUI. State Street Corp lifted its position in shares of ICU Medical by 9.3% in the third quarter. State Street Corp now owns 907,607 shares of the medical instruments supplier's stock valued at $165,384,000 after acquiring an additional 77,506 shares in the last quarter. Geode Capital Management LLC boosted its stake in ICU Medical by 9.6% during the third quarter. Geode Capital Management LLC now owns 546,954 shares of the medical instruments supplier's stock valued at $99,687,000 after buying an additional 48,106 shares during the last quarter. Charles Schwab Investment Management Inc. increased its position in ICU Medical by 10.2% in the third quarter. Charles Schwab Investment Management Inc. now owns 301,107 shares of the medical instruments supplier's stock worth $54,868,000 after purchasing an additional 27,927 shares during the last quarter. WCM Investment Management LLC grew its position in ICU Medical by 1.3% in the third quarter. WCM Investment Management LLC now owns 259,481 shares of the medical instruments supplier's stock worth $45,272,000 after acquiring an additional 3,407 shares in the last quarter. Finally, Victory Capital Management Inc. increased its position in shares of ICU Medical by 0.5% during the 3rd quarter. Victory Capital Management Inc. now owns 142,535 shares of the medical instruments supplier's stock valued at $25,973,000 after purchasing an additional 687 shares during the last quarter. Institutional investors own 96.10% of the company's stock.

Remove Ads

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on the stock. StockNews.com upgraded shares of ICU Medical from a "hold" rating to a "buy" rating in a report on Wednesday, November 20th. Needham & Company LLC reiterated a "hold" rating on shares of ICU Medical in a research note on Wednesday, November 13th. Jefferies Financial Group raised shares of ICU Medical from a "hold" rating to a "buy" rating and set a $200.00 price target on the stock in a report on Wednesday, December 11th. Finally, KeyCorp increased their price objective on shares of ICU Medical from $198.00 to $209.00 and gave the company an "overweight" rating in a research report on Wednesday, November 13th. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $199.67.

ICU Medical Price Performance

ICUI stock traded down $0.25 during mid-day trading on Friday, reaching $141.97. The company's stock had a trading volume of 244,234 shares, compared to its average volume of 220,167. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75. The company's 50 day moving average is $159.29 and its two-hundred day moving average is $165.76. The stock has a market cap of $3.48 billion, a PE ratio of -31.07 and a beta of 0.63. ICU Medical, Inc. has a fifty-two week low of $93.36 and a fifty-two week high of $196.26.

Insider Activity at ICU Medical

In related news, CEO Vivek Jain sold 1,373 shares of the firm's stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $155.48, for a total value of $213,474.04. Following the sale, the chief executive officer now owns 104,593 shares of the company's stock, valued at $16,262,119.64. This trade represents a 1.30 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 6.70% of the stock is owned by insiders.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.